Sintx Technologies (SINT) Cash from Financing Activities (2013 - 2026)
Sintx Technologies (SINT) recorded quarterly Cash from Financing Activities of $247000.0 in Q1 2026, down 10.51% quarter-over-quarter from $276000.0 in Q4 2025, and down 94.21% on a YoY basis from $4.3 million in Q1 2025.
Sintx Technologies (SINT) Cash from Financing Activities (2013 - 2026) Analysis & Trends
Sintx Technologies' Cash from Financing Activities history runs 14 years deep, the most recent figure standing at $247000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 94.21% year-over-year to $247000.0; the TTM figure through Mar 2026 stood at $4.2 million (down 47.95% YoY), while the FY2025 annual figure was $8.2 million, down 9.83% from the prior year.
- Cash from Financing Activities was $247000.0 for Q1 2026 at Sintx Technologies, down from $276000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $11.5 million in Q1 2023 to a low of -$123000.0 in Q2 2025.
- Historically, Cash from Financing Activities has averaged $2.5 million across 5 years, with a median of $1.0 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities surged 96025.0% in 2022, then plunged 132.8% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at $3.8 million in 2022, then sank by 91.91% to $311000.0 in 2023, then slumped by 132.8% to -$102000.0 in 2024, then surged by 370.59% to $276000.0 in 2025, then dropped by 10.51% to $247000.0 in 2026.
- The last three Cash from Financing Activities figures came in at $247000.0 (Q1 2026), $276000.0 (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Sintx Technologies | 8.59 Mn | 6.70 Mn | 144,000.00 | 247,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 247,000.00 |
| Mar 31, 2026 | 247,000.00 |
| Dec 31, 2025 | 276,000.00 |
| Dec 31, 2025 | 276,000.00 |
| Sep 30, 2025 | 3.78 Mn |
| Sep 30, 2025 | 3.78 Mn |
| Jun 30, 2025 | -123,000.00 |
| Jun 30, 2025 | -123,000.00 |
| Mar 31, 2025 | 4.27 Mn |
| Mar 31, 2025 | 4.27 Mn |
| Dec 31, 2024 | -102,000.00 |
| Dec 31, 2024 | -102,000.00 |
| Sep 30, 2024 | 2.86 Mn |
| Sep 30, 2024 | 2.86 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 5.33 Mn |
| Mar 31, 2024 | 5.33 Mn |
| Dec 31, 2023 | 311,000.00 |
| Dec 31, 2023 | 311,000.00 |